SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001697884-21-000024
Filing Date
2021-12-23
Accepted
2021-12-23 12:21:25
Documents
39
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 vsbc10qoct_2021.htm   iXBRL 10-Q 360194
2 ex31_1.htm EX-31.1 10931
3 ex31_2.htm EX-31.2 10789
4 ex32_1.htm EX-32.1 4128
5 ex32_2.htm EX-32.2 4050
  Complete submission text file 0001697884-21-000024.txt   1817736

Data Files

Seq Description Document Type Size
6 none-20211031.xsd EX-101.SCH 11607
7 none-20211031_cal.xml EX-101.CAL 20520
8 none-20211031_def.xml EX-101.DEF 17408
9 none-20211031_lab.xml EX-101.LAB 126856
10 none-20211031_pre.xml EX-101.PRE 93263
33 EXTRACTED XBRL INSTANCE DOCUMENT vsbc10qoct_2021_htm.xml XML 196632
Mailing Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DR. #1620 IRVINE CA 92618 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 211516128
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services